Vertex Pharmaceuticals Correlations
| VX1 Stock | EUR 441.80 3.80 0.87% |
The correlation of Vertex Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Vertex Pharmaceuticals Correlation With Market
Modest diversification
The correlation between Vertex Pharmaceuticals Incorpo and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals Incorpo and DJI in the same portfolio, assuming nothing else is changed.
Vertex |
The ability to find closely correlated positions to Vertex Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vertex Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vertex Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vertex Pharmaceuticals Incorporated to buy it.
Moving against Vertex Stock
| 0.49 | VOW3 | Volkswagen AG VZO | PairCorr |
| 0.48 | VOW3 | Volkswagen AG | PairCorr |
| 0.47 | VOWB | VOLKSWAGEN AG VZ | PairCorr |
| 0.46 | VOW | Volkswagen AG | PairCorr |
| 0.42 | 0QF | Moderna | PairCorr |
| 0.34 | MBG | Mercedes Benz Group | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Vertex Stock performing well and Vertex Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vertex Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 8SP | 2.10 | (0.08) | 0.00 | 0.28 | 0.00 | 3.38 | 20.22 | |||
| 6NM | 1.23 | 0.12 | (0.02) | (0.27) | 1.76 | 2.79 | 9.64 | |||
| 39O1 | 3.77 | 0.19 | 0.04 | 0.34 | 3.51 | 8.41 | 34.42 | |||
| 2DG | 3.89 | (1.59) | 0.00 | (2.90) | 0.00 | 6.45 | 52.42 | |||
| TLX | 0.97 | 0.00 | (0.06) | 0.00 | 1.13 | 2.67 | 7.58 | |||
| TM9 | 2.78 | (0.03) | (0.02) | 0.04 | 4.26 | 5.56 | 36.50 | |||
| INVN | 2.16 | 0.26 | 0.04 | (1.02) | 2.54 | 5.61 | 14.01 | |||
| IUI1 | 1.27 | 0.25 | 0.13 | 0.88 | 1.09 | 3.28 | 10.01 | |||
| 6HW | 0.42 | (0.11) | 0.00 | 1.46 | 0.00 | 1.21 | 5.39 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vertex Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Vertex Pharmaceuticals Corporate Management
Elected by the shareholders, the Vertex Pharmaceuticals' board of directors comprises two types of representatives: Vertex Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vertex. The board's role is to monitor Vertex Pharmaceuticals' management team and ensure that shareholders' interests are well served. Vertex Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vertex Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeffrey MD | Ex Chairman | Profile | |
| Ourania Tatsis | Ex Officer | Profile | |
| MD FASN | Pres CEO | Profile | |
| Susie Lisa | VP Relations | Profile | |
| Stuart BSc | Ex COO | Profile | |
| Mike Tirozzi | SVP Officer | Profile | |
| Damian Esq | Chief VP | Profile |